We are live on
!
Find out more
Vanguard Global Advisers Portfolio holdings
AUM
$215B
This Fund
S&P 500
This Quarter
Est. Return
-1.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187B
AUM Growth
–
Cap. Flow
+$194B
Cap. Flow
% of AUM
104.07%
Top 10 Holdings %
Top 10 Hldgs %
40.78%
Holding
3,683
New
3,683
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$24.8B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$12.4B |
| 3 |
NVIDIA
NVDA
|
+$9.74B |
| 4 |
Apple
AAPL
|
+$8.35B |
| 5 |
Microsoft
MSFT
|
+$6.8B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.86% |
| 2 | Financials | 11.48% |
| 3 | Communication Services | 7.14% |
| 4 | Consumer Discretionary | 7.01% |
| 5 | Healthcare | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Lincoln Electric
LECO
$15.6B
| $5.66M | ﹤0.01% |
+22,712
| New | +$6.08M |
|
727
Darling Ingredients
DAR
$10.6B
| $5.59M | ﹤0.01% |
+90,422
| New | +$4.45M |
|
728
HEICO Corp
HEI
$52.4B
| $5.59M | ﹤0.01% |
+20,389
| New | +$6.56M |
|
729
Rocket Companies
RKT
$41.8B
| $5.58M | ﹤0.01% |
+391,740
| New | +$7.13M |
|
730
BridgeBio Pharma
BBIO
$15.6B
| $5.58M | ﹤0.01% |
+75,104
| New | +$5.44M |
|
731
Tradeweb Markets
TW
$22.4B
| $5.56M | ﹤0.01% |
+47,242
| New | +$5.41M |
|
|
WCC
732
WESCO International
WCC
$17.6B
| $5.55M | ﹤0.01% |
+20,299
| New | +$5.7M |
|
|
SF
733
Stifel
SF
$12.9B
| $5.54M | ﹤0.01% |
+74,991
| New | +$5.95M |
|
734
Sterling Infrastructure
STRL
$17.6B
| $5.54M | ﹤0.01% |
+13,604
| New | +$5.32M |
|
735
Carlisle Companies
CSL
$14.7B
| $5.52M | ﹤0.01% |
+16,551
| New | +$6.02M |
|
736
Arrow Electronics
ARW
$10.9B
| $5.52M | ﹤0.01% |
+38,489
| New | +$5.28M |
|
737
Five Below
FIVE
$13.5B
| $5.52M | ﹤0.01% |
+24,145
| New | +$5.05M |
|
738
Hecla Mining
HL
$12.3B
| $5.51M | ﹤0.01% |
+295,769
| New | +$6.66M |
|
739
BioMarin Pharmaceuticals
BMRN
$13B
| $5.51M | ﹤0.01% |
+97,463
| New | +$5.68M |
|
740
Albertsons Companies
ACI
$6.03B
| $5.48M | ﹤0.01% |
+321,666
| New | +$5.58M |
|
741
LKQ Corp
LKQ
$6.43B
| $5.45M | ﹤0.01% |
+185,699
| New | +$5.96M |
|
742
Elanco Animal Health
ELAN
$11.8B
| $5.45M | ﹤0.01% |
+227,786
| New | +$5.57M |
|
743
Affirm
AFRM
$26.2B
| $5.45M | ﹤0.01% |
+118,944
| New | +$6.87M |
|
744
Ionis Pharmaceuticals
IONS
$9.51B
| $5.4M | ﹤0.01% |
+71,911
| New | +$5.68M |
|
745
Coca-Cola Europacific Partners
CCEP
$47.6B
| $5.38M | ﹤0.01% |
+58,926
| New | +$5.66M |
|
746
Performance Food Group
PFGC
$16.8B
| $5.38M | ﹤0.01% |
+62,817
| New | +$5.74M |
|
747
Guardant Health
GH
$21.1B
| $5.36M | ﹤0.01% |
+58,062
| New | +$5.83M |
|
748
Neurocrine Biosciences
NBIX
$15.5B
| $5.35M | ﹤0.01% |
+40,647
| New | +$5.39M |
|
749
Wintrust Financial
WTFC
$11B
| $5.35M | ﹤0.01% |
+38,536
| New | +$5.59M |
|
750
Dick's Sporting Goods
DKS
$18.1B
| $5.35M | ﹤0.01% |
+26,970
| New | +$5.47M |
|
Similar funds
Vanguard Global Advisers's Q1 2026 Portfolio in Review
Q1 2026 is the first quarter with a 13F filing on record for Vanguard Global Advisers, which disclosed 3,683 positions worth $187B. Its ten largest holdings account for 41% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, followed by Financials and Communication Services.
- Vanguard Global Advisers's largest Q1 2026 buy was Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
- Vanguard Global Advisers's ten largest holdings make up 41% of its $187B portfolio in Q1 2026.
- Vanguard Global Advisers disclosed 3,683 positions in Q1 2026, its first 13F filing on record.
Based on Vanguard Global Advisers's 13F filing for Q1 2026, filed 8 May 2026.